超崩壊剤の世界市場レポート 2025年

超崩壊剤市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR6.3％で14億8,000万米ドルに成長します。予測期間中の成長は、経口固形剤に対する需要の増加、慢性疾患の有病率の上昇、医薬品製造の拡大、効果的なドラッグデリバリーソリューションに対するニーズの高まりによるものです。予測期間中の主要動向としては、製造における技術の統合、共加工賦形剤の発展、天然と生分解性超崩壊剤へのシフト、革新的ドラッグデリバリーシステムの開発、賦形剤メーカーと製薬会社の連携強化などが挙げられます。

ジェネリック医薬品の生産の増加は、超崩壊剤市場の成長を促進すると予想されます。ジェネリック医薬品は、有効成分、用量、強さ、投与経路、品質、性能は先発医薬品と同じであるが、一般に安価で入手できます。ジェネリック医薬品の生産が増加している背景には、手頃な価格の医薬品に対する需要の高まり、ブランド医薬品の特許切れ、ヘルスケアコストの削減を目的とした政府の取り組みなどがあります。超崩壊剤は、錠剤の崩壊・溶出を促進し、薬剤の迅速な放出、バイオアベイラビリティの向上、患者のコンプライアンス向上につながるなど、ジェネリック医薬品の製剤において重要な役割を果たしています。例えば、2023年1月、米国の政府機関である食品医薬品局（FDA）は、2022年には米国内の処方箋の約91％がジェネリック医薬品で満たされ、これまでに3万2,000以上のジェネリック医薬品がFDAによって承認されたと報告しました。その結果、ジェネリック医薬品の生産が増加し、超崩壊剤市場の拡大に寄与しています。

超崩壊剤市場の主要企業は、医薬品の製剤効率を高め、錠剤の崩壊を促進し、医薬品用途における患者のコンプライアンスを改善するために、多機能崩壊剤などの革新的なソリューションに注力しています。多機能崩壊剤は、錠剤の製剤効率と薬剤放出を最適化するために、崩壊性、結合性、流動性を高める特性を併せ持つ先進的賦形剤です。例えば、2023年6月、米国の化学品会社Ashland Inc.は、医薬品製造時の錠剤崩壊性、粉末流動性、潤滑性を改善するために設計された共加工の多機能直接打錠型超崩壊剤であるPolyplasdone Plusを発表しました。この技術革新は、2つの製造プロセスを省き、錠剤の硬度を高め、高速かつ連続的な製造プロセスをサポートすることで、生産を合理化します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場-マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の超崩壊剤PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の超崩壊剤市場：成長率分析
• 世界の超崩壊剤市場の実績：規模と成長、2019～2024年
• 世界の超崩壊剤市場の予測：規模と成長、2024～2029年、2034年
• 世界の超崩壊剤総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の超崩壊剤市場：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 天然超崩壊剤
• 合成超崩壊剤
• その他の超崩壊剤
• 世界の超崩壊剤市場：配合別、実績と予測、2019～2024年、2024～2029年、2034年
• 錠剤
• カプセル
• 世界の超崩壊剤市場：治療領域別、実績と予測、2019～2024年、2024～2029年、2034年
• 消化器疾患
• 神経疾患
• 腫瘍学
• 感染症
• 心血管疾患
• 血液疾患
• 世界の超崩壊剤市場、天然超崩壊剤のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• スターチ
• セルロース
• キトサン
• ゴム
• 世界の超崩壊剤市場、合成超崩壊剤のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 架橋ポリビニルピロリドン（クロスポビドン）
• デンプングリコール酸ナトリウム
• クロスカルメロースナトリウム
• その他の合成超崩壊剤
• 世界の超崩壊剤市場、その他の超崩壊剤のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• イオン交換樹脂
• 界面活性剤ベースの超崩壊剤
• その他の専門超崩壊剤

第7章 地域別・国別分析

• 世界の超崩壊剤市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の超崩壊剤市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 超崩壊剤市場：競合情勢
• 超崩壊剤市場：企業プロファイル
  • BASF SE
  • Merck KGaA
  • DuPont de Nemours Inc.
  • IFF Pharma Solutions
  • Ingredion Incorporated

第31章 その他の大手企業と革新的企業

• Roquette Freres SA.
• FMC Corporation
• Azelis Group
• Ashland Inc.
• Piramal Healthcare
• Colorcon Inc. Ltd.
• Boai NKY Pharmaceuticals Ltd.
• JRS Pharma
• Faran Shimi Pharmaceutical
• DFE Pharma India Private Limited.
• Sigachi Industries Limited
• Corel Pharma Chem
• Maple BIoTech Pvt. Ltd.
• Shanghai Chineway Pharmaceutical Technology Co. Ltd.
• JH Nanhang Life Sciences Co. Ltd

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、戦略

• 超崩壊剤市場、2029年：新たな機会を提供する国
• 超崩壊剤市場、2029年：新たな機会を提供するセグメント
• 超崩壊剤市場、2029年：成長戦略
  • 市場動向による戦略
  • 競合の戦略

第36章 付録

Superdisintegrants are pharmaceutical excipients specifically formulated to accelerate the disintegration of tablets or capsules, enabling faster release and absorption of the active pharmaceutical ingredient (API) in the body. They are essential for enhancing drug bioavailability and ensuring efficacy, particularly in orally administered medications.

The primary categories of superdisintegrants include natural, synthetic, and other types. Natural superdisintegrants are plant-based or naturally derived substances that aid in the breakdown of tablets within the gastrointestinal tract, improving drug dissolution and absorption. These excipients are used in various formulations, such as tablets and capsules, and play a vital role in treating a range of therapeutic areas, including gastrointestinal diseases, neurological disorders, oncology, infectious diseases, cardiovascular conditions, and hematological diseases.

The superdisintegrants market research report is one of a series of new reports from The Business Research Company that provides superdisintegrants market statistics, including the superdisintegrants industry global market size, regional shares, competitors with the superdisintegrants market share, detailed superdisintegrants market segments, market trends, and opportunities, and any further data you may need to thrive in the superdisintegrants industry. This superdisintegrants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The superdisintegrants market size has grown strongly in recent years. It will grow from $1.09 billion in 2024 to $1.16 billion in 2025 at a compound annual growth rate (CAGR) of 6.5%. The growth during the historic period can be credited to the increasing prevalence of chronic and lifestyle-related diseases, the expansion of the global pharmaceutical industry, the rising demand for orally disintegrating tablets (ODTs), the growing geriatric and pediatric populations, and the heightened focus on enhancing drug bioavailability.

The superdisintegrants market size is expected to see strong growth in the next few years. It will grow to $1.48 billion in 2029 at a compound annual growth rate (CAGR) of 6.3%. The growth during the forecast period can be credited to the increasing demand for oral solid dosage forms, the rising prevalence of chronic diseases, the expansion of pharmaceutical manufacturing, and the growing need for effective drug delivery solutions. Key trends in the forecast period include the integration of technology in manufacturing, advancements in co-processed excipients, a shift toward natural and biodegradable superdisintegrants, the development of innovative drug-delivery systems, and enhanced collaboration between excipient manufacturers and pharmaceutical companies.

The increasing production of generic drugs is expected to drive the growth of the superdisintegrants market. Generic drugs contain the same active ingredients, dosage, strength, route of administration, quality, and performance as brand-name drugs but are generally available at a lower cost. The rising production of generic drugs is fueled by the growing demand for affordable medications, the expiration of patents for branded drugs, and government initiatives aimed at reducing healthcare costs. Superdisintegrants play a crucial role in generic drug formulations by enhancing tablet disintegration and dissolution, leading to faster drug release, improved bioavailability, and better patient compliance. For example, in January 2023, the Food and Drug Administration (FDA), a US-based government agency, reported that in 2022, approximately 91% of prescriptions in the United States were filled with generic drugs, with over 32,000 generic medications having been approved by the FDA to date. As a result, the increasing production of generic drugs is contributing to the expansion of the superdisintegrants market.

Key companies in the superdisintegrants market are focusing on innovative solutions, such as multifunctional disintegrants, to enhance drug formulation efficiency, accelerate tablet disintegration, and improve patient compliance in pharmaceutical applications. Multifunctional disintegrants are advanced excipients that combine disintegration, binding, and flow-enhancing properties to optimize tablet formulation efficiency and drug release. For instance, in June 2023, Ashland Inc., a US-based chemicals company, introduced Polyplasdone Plus, a co-processed multifunctional direct compression superdisintegrant designed to improve tablet disintegration, powder flow, and lubrication during pharmaceutical manufacturing. This innovation streamlines production by eliminating two manufacturing steps, enhancing tablet hardness, and supporting high-speed and continuous manufacturing processes.

In April 2023, Ingredion Inc., a US-based food company, acquired Amishi Drugs & Chemicals Private Limited for an undisclosed amount. Through this acquisition, Ingredion aims to expand its portfolio of specialty pharmaceutical products, strengthen its expertise in functional excipients, establish a stronger presence in the rapidly growing Indian pharmaceutical market, and support global exports with high-quality, pharma-grade ingredients. Amishi Drugs & Chemicals Private Limited is an India-based company specializing in the production of superdisintegrants for enhanced tablet disintegration and drug formulation.

Major players in the superdisintegrants market are BASF SE, Merck KGaA, DuPont de Nemours Inc., IFF Pharma Solutions, Ingredion Incorporated, Roquette Freres SA., FMC Corporation, Azelis Group, Ashland Inc., Piramal Healthcare, Colorcon Inc. Ltd., Boai NKY Pharmaceuticals Ltd., JRS Pharma, Faran Shimi Pharmaceutical, DFE Pharma India Private Limited., Sigachi Industries Limited, Corel Pharma Chem, Maple Biotech Pvt. Ltd., Shanghai Chineway Pharmaceutical Technology Co. Ltd., and JH Nanhang Life Sciences Co. Ltd.

North America was the largest region in the superdisintegrants market in 2024. The regions covered in superdisintegrants report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the superdisintegrants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The superdisintegrants market consists of sales of co-processed superdisintegrants, polymer-based superdisintegrants, and cross-linked superdisintegrants. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Superdisintegrants Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on superdisintegrants market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for superdisintegrants ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The superdisintegrants market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Natural Superdisintegrants; Synthetic Superdisintegrants; Other Superdisintegrants
• 2) By Formulation: Tablets; Capsules
• 3) By Therapeutic Area: Gastrointestinal Diseases; Neurological Diseases; Oncology; Infectious Diseases; Cardiovascular Diseases; Hematological Diseases
• Subsegments:
• 1) By Natural Superdisintegrants: Starch; Cellulose; Chitosan; Gums; Other Natural Superdisintegrants
• 2) By Synthetic Superdisintegrants: Cross-linked Polyvinylpyrrolidone (Crospovidone); Sodium Starch Glycolate; Croscarmellose Sodium; Other Synthetic Superdisintegrants
• 3) By Other Superdisintegrants: Ion Exchange Resins; Surfactant-Based Superdisintegrants; Other Specialized Superdisintegrants
• Companies Mentioned: BASF SE; Merck KGaA; DuPont de Nemours Inc.; IFF Pharma Solutions; Ingredion Incorporated
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Superdisintegrants Market Characteristics

3. Superdisintegrants Market Trends And Strategies

4. Superdisintegrants Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Superdisintegrants Growth Analysis And Strategic Analysis Framework

• 5.1. Global Superdisintegrants PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Superdisintegrants Market Growth Rate Analysis
• 5.4. Global Superdisintegrants Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Superdisintegrants Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Superdisintegrants Total Addressable Market (TAM)

6. Superdisintegrants Market Segmentation

• 6.1. Global Superdisintegrants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Natural Superdisintegrants
• Synthetic Superdisintegrants
• Other Superdisintegrants
• 6.2. Global Superdisintegrants Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tablets
• Capsules
• 6.3. Global Superdisintegrants Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Gastrointestinal Diseases
• Neurological Diseases
• Oncology
• Infectious Diseases
• Cardiovascular Diseases
• Hematological Diseases
• 6.4. Global Superdisintegrants Market, Sub-Segmentation Of Natural Superdisintegrants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Starch
• Cellulose
• Chitosan
• Gums
• 6.5. Global Superdisintegrants Market, Sub-Segmentation Of Synthetic Superdisintegrants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cross-linked Polyvinylpyrrolidone (Crospovidone)
• Sodium Starch Glycolate
• Croscarmellose Sodium
• Other Synthetic Superdisintegrants
• 6.6. Global Superdisintegrants Market, Sub-Segmentation Of Other Superdisintegrants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ion Exchange Resins
• Surfactant-Based Superdisintegrants
• Other Specialized Superdisintegrants

7. Superdisintegrants Market Regional And Country Analysis

• 7.1. Global Superdisintegrants Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Superdisintegrants Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Superdisintegrants Market

• 8.1. Asia-Pacific Superdisintegrants Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Superdisintegrants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Superdisintegrants Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Superdisintegrants Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Superdisintegrants Market

• 9.1. China Superdisintegrants Market Overview
• 9.2. China Superdisintegrants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Superdisintegrants Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Superdisintegrants Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Superdisintegrants Market

• 10.1. India Superdisintegrants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Superdisintegrants Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Superdisintegrants Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Superdisintegrants Market

• 11.1. Japan Superdisintegrants Market Overview
• 11.2. Japan Superdisintegrants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Superdisintegrants Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Superdisintegrants Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Superdisintegrants Market

• 12.1. Australia Superdisintegrants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Superdisintegrants Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Superdisintegrants Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Superdisintegrants Market

• 13.1. Indonesia Superdisintegrants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Superdisintegrants Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Superdisintegrants Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Superdisintegrants Market

• 14.1. South Korea Superdisintegrants Market Overview
• 14.2. South Korea Superdisintegrants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Superdisintegrants Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Superdisintegrants Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Superdisintegrants Market

• 15.1. Western Europe Superdisintegrants Market Overview
• 15.2. Western Europe Superdisintegrants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Superdisintegrants Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Superdisintegrants Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Superdisintegrants Market

• 16.1. UK Superdisintegrants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Superdisintegrants Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Superdisintegrants Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Superdisintegrants Market

• 17.1. Germany Superdisintegrants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Superdisintegrants Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Superdisintegrants Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Superdisintegrants Market

• 18.1. France Superdisintegrants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Superdisintegrants Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Superdisintegrants Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Superdisintegrants Market

• 19.1. Italy Superdisintegrants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Superdisintegrants Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Superdisintegrants Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Superdisintegrants Market

• 20.1. Spain Superdisintegrants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Superdisintegrants Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Superdisintegrants Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Superdisintegrants Market

• 21.1. Eastern Europe Superdisintegrants Market Overview
• 21.2. Eastern Europe Superdisintegrants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Superdisintegrants Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Superdisintegrants Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Superdisintegrants Market

• 22.1. Russia Superdisintegrants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Superdisintegrants Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Superdisintegrants Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Superdisintegrants Market

• 23.1. North America Superdisintegrants Market Overview
• 23.2. North America Superdisintegrants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Superdisintegrants Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Superdisintegrants Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Superdisintegrants Market

• 24.1. USA Superdisintegrants Market Overview
• 24.2. USA Superdisintegrants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Superdisintegrants Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Superdisintegrants Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Superdisintegrants Market

• 25.1. Canada Superdisintegrants Market Overview
• 25.2. Canada Superdisintegrants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Superdisintegrants Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Superdisintegrants Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Superdisintegrants Market

• 26.1. South America Superdisintegrants Market Overview
• 26.2. South America Superdisintegrants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Superdisintegrants Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Superdisintegrants Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Superdisintegrants Market

• 27.1. Brazil Superdisintegrants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Superdisintegrants Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Superdisintegrants Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Superdisintegrants Market

• 28.1. Middle East Superdisintegrants Market Overview
• 28.2. Middle East Superdisintegrants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Superdisintegrants Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Superdisintegrants Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Superdisintegrants Market

• 29.1. Africa Superdisintegrants Market Overview
• 29.2. Africa Superdisintegrants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Superdisintegrants Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Superdisintegrants Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Superdisintegrants Market Competitive Landscape And Company Profiles

• 30.1. Superdisintegrants Market Competitive Landscape
• 30.2. Superdisintegrants Market Company Profiles
  • 30.2.1. BASF SE Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. DuPont de Nemours Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. IFF Pharma Solutions Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Ingredion Incorporated Overview, Products and Services, Strategy and Financial Analysis

31. Superdisintegrants Market Other Major And Innovative Companies

• 31.1. Roquette Freres SA.
• 31.2. FMC Corporation
• 31.3. Azelis Group
• 31.4. Ashland Inc.
• 31.5. Piramal Healthcare
• 31.6. Colorcon Inc. Ltd.
• 31.7. Boai NKY Pharmaceuticals Ltd.
• 31.8. JRS Pharma
• 31.9. Faran Shimi Pharmaceutical
• 31.10. DFE Pharma India Private Limited.
• 31.11. Sigachi Industries Limited
• 31.12. Corel Pharma Chem
• 31.13. Maple Biotech Pvt. Ltd.
• 31.14. Shanghai Chineway Pharmaceutical Technology Co. Ltd.
• 31.15. JH Nanhang Life Sciences Co. Ltd

32. Global Superdisintegrants Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Superdisintegrants Market

34. Recent Developments In The Superdisintegrants Market

35. Superdisintegrants Market High Potential Countries, Segments and Strategies

• 35.1 Superdisintegrants Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Superdisintegrants Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Superdisintegrants Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer